GALMOZZI, ENRICO
 Distribuzione geografica
Continente #
EU - Europa 3.492
NA - Nord America 2.427
AS - Asia 2.392
SA - Sud America 253
AF - Africa 50
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.639
Nazione #
US - Stati Uniti d'America 2.311
GB - Regno Unito 1.393
CN - Cina 913
SG - Singapore 641
DE - Germania 601
IT - Italia 358
SE - Svezia 268
FR - Francia 237
RU - Federazione Russa 195
BR - Brasile 186
HK - Hong Kong 166
BD - Bangladesh 133
IN - India 102
VN - Vietnam 96
NL - Olanda 89
TR - Turchia 86
CA - Canada 82
IE - Irlanda 69
FI - Finlandia 60
DK - Danimarca 58
UA - Ucraina 58
KR - Corea 57
JP - Giappone 49
TW - Taiwan 39
EU - Europa 36
ID - Indonesia 30
PL - Polonia 27
MX - Messico 26
AU - Australia 23
CO - Colombia 23
EG - Egitto 16
AR - Argentina 15
GR - Grecia 15
ES - Italia 13
BE - Belgio 12
IQ - Iraq 10
VE - Venezuela 10
MA - Marocco 9
TH - Thailandia 9
IR - Iran 8
PK - Pakistan 7
RO - Romania 7
UZ - Uzbekistan 7
EC - Ecuador 6
TN - Tunisia 6
AT - Austria 5
MM - Myanmar 5
PE - Perù 5
PH - Filippine 5
CH - Svizzera 4
CI - Costa d'Avorio 4
DZ - Algeria 4
IL - Israele 4
PT - Portogallo 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
HU - Ungheria 3
LB - Libano 3
MY - Malesia 3
NP - Nepal 3
RS - Serbia 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
HN - Honduras 2
KE - Kenya 2
KH - Cambogia 2
LU - Lussemburgo 2
PR - Porto Rico 2
PY - Paraguay 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
BH - Bahrain 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
GN - Guinea 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MK - Macedonia 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
QA - Qatar 1
SN - Senegal 1
TM - Turkmenistan 1
ZW - Zimbabwe 1
Totale 8.674
Città #
Southend 1.310
Singapore 381
Chandler 240
Ashburn 217
Beijing 186
San Jose 154
Hong Kong 147
Milan 140
Seattle 121
Wilmington 94
Hanover 92
Princeton 89
Frankfurt am Main 74
Dallas 69
Dublin 66
Cambridge 57
Council Bluffs 56
New York 56
Ann Arbor 54
Woodbridge 52
Los Angeles 50
Fairfield 49
Houston 45
Mountain View 43
Dearborn 42
Shanghai 41
Nanjing 39
Toronto 39
Santa Clara 38
Lauterbourg 36
Munich 34
Guangzhou 32
Andover 31
Redmond 30
Moscow 29
Redwood City 29
Des Moines 28
Scranton 28
Bengaluru 27
Ho Chi Minh City 27
Somerville 26
Boardman 25
Jacksonville 25
Buffalo 24
Sakarya 22
Kiez 21
São Paulo 21
Hanoi 20
Hangzhou 19
Helsinki 19
Bogotá 18
Taichung 18
Warsaw 18
Columbus 17
Phoenix 17
Serra 17
Berlin 15
Cangzhou 15
Changsha 15
Jakarta 15
Hebei 14
Odernheim 14
The Dalles 14
Tianjin 14
Tokyo 14
Jinan 13
Nürnberg 13
Shenzhen 13
Grafing 12
Saint Petersburg 12
Shenyang 12
Athens 11
Eitensheim 11
Hamburg 11
Hefei 11
Montreal 11
Brussels 10
Fuzhou 10
Turin 10
Groningen 9
Guadalajara 9
Mumbai 9
Nuremberg 9
Ottawa 9
Rome 9
Chengdu 8
Jiaxing 8
Margão 8
Nanchang 8
Taipei 8
Turku 8
Brisbane 7
Cairo 7
Da Nang 7
Delhi 7
Fairfax 7
Orem 7
Quanzhou 7
Silver Spring 7
Taiyuan 7
Totale 5.154
Nome #
Melanoma contains CD133 and ABCG2 positive cells with enhanced tumorigenic potential 806
Hepatic Fat-Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAs 597
Cirrhosis and rapid virological response to peginterferon plus ribavirin determine treatment outcome in HCV-1 IL28B rs12979860 CC patients 392
The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependent 345
Donor/recipient match of IL28B to predict interferon response in recurrent hepatitis C 290
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype 281
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype 277
Homozygosity for the PNPLA3/Adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease 270
Cancer stem cells and therapeutic perspectives 265
Limited utility of ITPA deficiency to predict early anemia in HCV patients with advanced fibrosis receiving telaprevir 252
Beta-globin mutations are associated with parenchymal siderosis and fibrosis severity in patients with nonalcoholic fatty liver disease 232
Increased levels of the CD40 : CD40 ligand dyad in the cerebrospinal fluid of rats with vitamin B12(cobalamin)-deficient central neuropathy 229
Allelic inhibition of displacement activity : a simplified one tube allele-specific PCR for evaluation of ITPA polymorphisms 224
Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C 224
Inosine triphosphatase deficiency helps predict anaemia, anaemia management and response in chronic hepatitis C therapy 219
TLL1 Variants do not predict hepatocellular carcinoma development in hcv cirrhotic patients treated with direct-acting antivirals 217
Tenofovir alafenamide as a rescue therapy in a patient with HBV-cirrhosis with a history of Fanconi syndrome and multidrug resistance 211
Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4 210
A tetra-primer amplification refractory mutation system polymerase chain reaction for the evaluation of rs12979860 IL28B genotype 205
Homozygosity for the PNPLA3/Adiponutrin I148m polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease 204
NPLA3 I148M polymorphism, steatosis, liver damage, and treatment response in chronic hepatitis C 201
Identification of stem cell like population in human melanoma 198
IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients 196
PNPLA3 I148M polymorphism, steatosis, liver damage, and treatment response in chronic hepatitis C 192
HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease 183
PNPLA3/adiponutrin genotype is strongly associated with metabolic syndrome components and liver damage in patients with non-alcoholic fatty liver disease 182
Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B 179
Interaction between the PNPLA3 I148M mutation, body weight, and steatosis, in determining the progression to cirrhosis in hereditary hemochromatosis 171
CD133 postive cellular population in human melanoma 170
Beta-globin mutations are associated with parenchymal siderosis and fibrosis severity in patients with nonalcoholic fatty liver disease 159
Genetic testing for hepatocellular carcinoma : an ambitious goal still to achieve 150
Homozygosity for the patatin-like phospholipase-3/adiponutrin i148m polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease 149
I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease 148
Systematic review with meta-analysis : do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection? 148
CD133 positive cellular population in human melanoma 148
PNPLA3/adiponutrin genotype is strongly associated with metabolic syndrome components and liver damage in patients with nonalcoholic liver disease 138
Letter: Do interferon lambda 3 polymorphisms predict the outcome of interferon therapy in hepatitis B infection? Authors' reply 125
Studies of IL28B genotype and response to peginterferon in chronic hepatitis B should be stratified by HBV genotype 124
Letter: Does the IFNL4 gene discovery really provide a causal role for the IL28B haplotype blocks? 117
Totale 9.028
Categoria #
all - tutte 21.563
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.563


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021209 0 0 0 0 0 0 0 0 0 0 123 86
2021/2022766 61 20 32 77 90 80 73 38 67 67 51 110
2022/2023728 102 101 80 71 68 132 14 43 63 9 32 13
2023/2024465 25 32 23 36 92 40 34 24 21 35 44 59
2024/20251.164 32 141 42 164 101 51 44 95 48 104 106 236
2025/20262.170 287 166 170 168 243 173 198 145 193 117 310 0
Totale 9.028